Nutex Health Financials - Benzinga

Nutex Health Inc

NUTXNASDAQ

Trade with Public

Trade with Public

$208.79

-5.53-2.58%

At close: Sep 18, 5:00 PM EST

$210.39

1.600.77%

After Hours: Sep 18, 4:09 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Nutex Health Financials

Nutex Health (NUTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Nutex Health Q2 EPS $9.38 Beats $4.95 Estimate, Sales $210.752M Miss $215.031M Estimate

Nutex Health (NASDAQ:NUTX) reported quarterly earnings of $9.38 per share which beat the analyst consensus estimate of $4.95 by 89.49 percent. This is a 417.97 percent increase over losses of $(2.95) per share from the

Benzinga Newsdesk

PRO
Nutex Health Q1 EPS $6.52 Beats $3.99 Estimate, Sales $216.485M Miss $227.894M Estimate

Nutex Health (NASDAQ:NUTX) reported quarterly earnings of $6.52 per share which beat the analyst consensus estimate of $3.99 by 63.41 percent. This is a 154.69 percent increase over earnings of $2.56 per share from the

Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

Nutex Health Earnings Report: Q4 Overview

Benzinga Insights

PRO
Nutex Health Q4 EPS $1.61 Misses $6.84 Estimate, Sales $151.679M Miss $258.816M Estimate

Benzinga Newsdesk

Earnings Scheduled For March 5, 2026

Benzinga Insights